LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Intuitive Surgical Inc

Suletud

SektorTervishoid

563.61 0.63

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

555.25

Max

563.83

Põhinäitajad

By Trading Economics

Sissetulek

16M

704M

Müük

-160M

2.3B

P/E

Sektori keskmine

82.442

56.602

Aktsiakasum

1.81

Kasumimarginaal

31.228

Töötajad

15,638

EBITDA

-91M

719M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+6.48% upside

Turustatistika

By TradingEconomics

Turukapital

-9B

201B

Eelmine avamishind

562.98

Eelmine sulgemishind

563.61

Uudiste sentiment

By Acuity

50%

50%

173 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bearish Evidence

Intuitive Surgical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. apr 2025, 20:55 UTC

Tulu

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23. jaan 2025, 21:41 UTC

Tulu

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21. jaan 2025, 18:37 UTC

Omandamised, ülevõtmised, äriostud

Intuitive to Establish Direct Presence in Europe With Acquisition

18. okt 2024, 15:22 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17. okt 2024, 21:33 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17. okt 2024, 20:56 UTC

Tulu

Intuitive Surgical Posts 3Q Revenue Growth

22. apr 2025, 20:13 UTC

Tulu

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q EPS $1.92 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Net $698.4M >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Rev $2.25B >ISRG

24. jaan 2025, 21:17 UTC

Tulu

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24. jaan 2025, 18:18 UTC

Tulu

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24. jaan 2025, 13:11 UTC

Peamised uudised

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24. jaan 2025, 09:51 UTC

Kuumad aktsiad

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23. jaan 2025, 21:10 UTC

Tulu

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23. jaan 2025, 21:09 UTC

Tulu

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23. jaan 2025, 21:09 UTC

Tulu

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Rev $2.41B >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Net $685.7M >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q EPS $1.88 >ISRG

15. jaan 2025, 17:27 UTC

Tulu

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6. jaan 2025, 12:00 UTC

Peamised uudised

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18. okt 2024, 15:59 UTC

Tulu

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18. okt 2024, 15:38 UTC

Tulu

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18. okt 2024, 13:28 UTC

Tulu

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17. okt 2024, 21:18 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

Võrdlus sarnastega

Hinnamuutus

Intuitive Surgical Inc Prognoos

Hinnasiht

By TipRanks

6.48% tõus

12 kuu keskmine prognoos

Keskmine 596.57 USD  6.48%

Kõrge 675 USD

Madal 470 USD

Põhineb 18 Wall Streeti analüütiku instrumendi Intuitive Surgical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

18 ratings

15

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

514.59 / 539.05Toetus ja vastupanu

Lühikene perspektiiv

Weak Bearish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

173 / 382 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.